EDWARDS LIFESCIENCES CORP

NYSE: EW (Edwards Lifesciences Corporatio)

Last update: 10 hours ago

81.44

0.45 (0.56%)

Previous Close 80.99
Open 80.95
Volume 4,648,444
Avg. Volume (3M) 4,821,001
Market Cap 47,300,354,048
Price / Earnings (TTM) 44.99
Price / Earnings (Forward) 27.25
Price / Sales 7.82
Price / Book 4.52
52 Weeks Range
69.21 (-15%) — 87.89 (7%)
Earnings Date 23 Apr 2026
Profit Margin 75.71%
Operating Margin (TTM) 29.01%
Diluted EPS (TTM) 2.42
Quarterly Revenue Growth (YOY) 6.20%
Quarterly Earnings Growth (YOY) 1.70%
Total Debt/Equity (MRQ) 6.86%
Current Ratio (MRQ) 4.45
Operating Cash Flow (TTM) 876.20 M
Levered Free Cash Flow (TTM) 1.45 B
Return on Assets (TTM) 8.42%
Return on Equity (TTM) 16.51%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Bearish
Medical Devices (Global) Mixed Bearish
Stock Edwards Lifesciences Corporatio Bullish Bullish

AIStockmoo Score

-0.8
Analyst Consensus 5.0
Insider Activity -4.0
Price Volatility -1.0
Technical Moving Averages -3.5
Technical Oscillators -0.5
Average -0.80

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
EW 47 B - 44.99 4.52
SNN 14 B 2.04% 22.44 2.74
SYK 130 B 1.02% 40.33 5.77
BSX 92 B - 31.96 3.94
ABT 167 B 1.85% 26.89 3.34
MDT 112 B 3.13% 24.36 2.26

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Sector Healthcare
Industry Medical Devices
Investment Style Mid Growth
% Held by Insiders 0.91%
% Held by Institutions 89.29%

Ownership

Name Date Shares Held
Brown Advisory Inc 31 Dec 2025 7,332,126
52 Weeks Range
69.21 (-15%) — 87.89 (7%)
Price Target Range
89.00 (9%) — 103.00 (26%)
High 103.00 (BTIG, 26.47%) Buy
Median 100.00 (22.79%)
Low 89.00 (Truist Securities, 9.28%) Hold
Average 97.40 (19.60%)
Total 4 Buy, 1 Hold
Avg. Price @ Call 79.33
Firm Date Target Price Call Price @ Call
BTIG 11 Feb 2026 103.00 (26.47%) Buy 79.33
Goldman Sachs 11 Feb 2026 95.00 (16.65%) Buy 79.33
Piper Sandler 11 Feb 2026 100.00 (22.79%) Buy 79.33
Truist Securities 11 Feb 2026 89.00 (9.28%) Hold 79.33
Wells Fargo 11 Feb 2026 100.00 (22.79%) Buy 79.33
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
ULLEM SCOTT B. - 79.15 -13,000 -1,028,950
Aggregate Net Quantity -13,000
Aggregate Net Value ($) -1,028,950
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 79.15
Name Holder Date Type Quantity Price Value ($)
ULLEM SCOTT B. Officer 09 Apr 2026 Automatic sell (-) 13,000 79.15 1,028,950
ULLEM SCOTT B. Officer 09 Apr 2026 Option execute 13,000 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria